Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Susan Kohlhaas

Controversial study claims this simple brain exercise can cut dementia risk by 25%

Further research is still needed to prove effects of such exercise, scientists say

The Independent UK

Researchers investigating if drugs can be repurposed to combat dementia

Developing new medications for diseases like Alzheimer’s can be very expensive, and take a long time.

The Independent UK

Alzheimer’s breakthrough as blood tests could be offered on NHS

Dementia affects around 900,000 people in the UK and experts predict that will rise to 1.4 million people by 2040

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Blood tests for Alzheimer’s could be offered on NHS within five years – experts

Less than two-thirds of people in England with dementia have a formal diagnosis.

The Independent UK

New drug found to slow Alzheimer’s hailed as turning point

Donanemab has been found to slow down the disease in a clinical trial.

The Independent UK

Everything we know about breakthrough Alzheimer’s drug Donanemab

Alzheimer’s disease is the most common cause of dementia in the UK

The Independent UK

Alzheimer’s: ‘Turning point’ in fight against disease as drug found to slow decline by up to 35%

Experts say ‘we’re entering a new era where Alzheimer’s disease could become treatable’

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Experts urge health regulators to approve ‘turning point’ dementia drugs

Exclusive: As results show 35% slowing in cognitive decline, health leaders say swift decisions crucial

The Guardian - UK

Hope for Alzheimer's patients as doctors develop drug to slow effect of illness

Experts said 'this could be the beginning of the end' of the disease after donanemab slowed brain decline by 36% in a late-stage clinical trial

Daily Mirror

Three or more concussions linked to worsened brain function in later life

The data comes from the PROTECT study.

The Independent UK

Alzheimer's disease could be slowed down by new drug as NHS urged to speed up testing

Lecanemab could mark 'the end of the beginning' in the decades-long fight against dementia, geneticist Prof Sir John Hardy said. The drug was found to reduce brain decline in those with mild dementia

Daily Mirror

Breakthrough Alzheimer’s drug could be in UK use in a year but only for minority

Only 5% of patients eligible for the drug will be able to access it – and most of these will be private cases, experts have said.

The Independent UK

Rugby authorities urged to cut out contact training to reduce the risk of motor neurone disease

New research has found evidence of an increased risk of motor neurone disease among former rugby players

The Independent UK

Rugby chiefs urged to end contact training to reduce motor neurone disease risk

A study led by the University of Glasgow looked at former Scotland internationals.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Rugby players 15 times more likely to develop motor neurone disease, new research finds

Research led by the University of Glasgow found evidence of an increased risk of motor neurone disease among former rugby players

The Independent UK

Rugby authorities urged to cut out contact training to reduce the risk of MND

Research led by the University of Glasgow found evidence of an increased risk of motor neurone disease among former rugby players.

Daily Mirror

5 bits of good news you might have missed this week - including Alzheimer's breakthrough

The news has been pretty bleak lately and it's been hard to keep up with all the sombre events that have been going on, so you may have missed a few stories that could make you a bit more hopeful for the future

Daily Mirror

First ever drug to treat Alzheimer's disease could be available to Brits in two years

The Lecanemab drug has been shown to reduce the decline in memory and thinking skills by 27% over 18 months in those with early-stage Alzheimer's - making it the only medication to treat the underlying disease

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Mirror

World's first EVER drug shown to work against Alzheimer's developed by scientists

Scientists say the development of the only drug to work against Alzheimer’s is a 'historic moment' - with regulators expected to approve the groundbreaking drug by the New Year

The Independent UK

‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’

The new clinical trial found that there was a significant reduction in the decline in memory and thinking usually seen in early-stage patients.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organisation

University College London

181 stories

Orsted

158 stories

University of Glasgow

150 stories

Alzheimer Research UK

148 stories

University of Oxford

141 stories

the University of Manchester

99 stories

Eisai

79 stories

Eli Lilly and Company

58 stories

the Alzheimer Society

44 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.